Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $34.8 million.

  • Lifecore Biomedical, Inc. \De\'s Shares Outstanding (Diluted Average) fell 501.74% to $34.8 million in Q2 2025 from the same period last year, while for May 2025 it was $34.8 million, marking a year-over-year decrease of 501.74%. This contributed to the annual value of $34.8 million for FY2025, which is 501.74% down from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Shares Outstanding (Diluted Average) stood at $34.8 million for Q2 2025, which was down 501.74% from $37.0 million recorded in Q1 2025.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Shares Outstanding (Diluted Average) peaked at $37.0 million during Q1 2025, and registered a low of $29.3 million during Q2 2021.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Shares Outstanding (Diluted Average) value was $30.1 million (recorded in 2023), while the average stood at $31.8 million.
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Shares Outstanding (Diluted Average) soared by 2289.63% in 2023 and then plummeted by 565.21% in 2024.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Shares Outstanding (Diluted Average) stood at $29.5 million in 2021, then rose by 0.55% to $29.6 million in 2022, then grew by 22.9% to $36.4 million in 2023, then fell by 5.65% to $34.4 million in 2024, then increased by 1.33% to $34.8 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $34.8 million for Q2 2025, versus $37.0 million for Q1 2025 and $34.4 million for Q4 2024.